[Solubility pattern of 2 crystallization modifications of 2-benzosulfonamido-5-(beta-hydroxyethoxy-)pyrimidines].
作者信息
Köhler H J, Speiser P, Soliva M
出版信息
Pharm Acta Helv. 1975;50(1-2):17-24.
PMID:1114157
Abstract
摘要
相似文献
1
2
Letter: Dimorphism of pyrimidine bases.信件：嘧啶碱基的二态性。
Acta Pol Pharm. 1974;31(1):121-2.
3
The polymorphism of indomethacine. New modifications, their melting behavior and solubility.
Acta Pharm Suec. 1974 Jun;11(3):295-303.
4
Effect of additives on the kinetics of interconversion of sulphamethoxydiazine crystal forms.添加剂对磺胺甲氧基嘧啶晶型相互转化动力学的影响。
J Pharm Pharmacol. 1973 Jan;25(1):13-20. doi: 10.1111/j.2042-7158.1973.tb09109.x.
5
[Sulfonamides. I. Sulfonamide derivatives of pyrazole and pyrazolone-5].[磺胺类药物。I. 吡唑和5-吡唑啉酮的磺胺衍生物]
Acta Pol Pharm. 1975;32(2):149-58.
6
Studies on oxidative modifications of nucleic acid pyrimidine bases.核酸嘧啶碱基的氧化修饰研究。
Nucleic Acids Symp Ser. 1984(15):1-4.
7
[Amelioration and normalization of the rapidity of dissolution by microcrystallization: application to methylprednisolone].通过微晶化改善并使溶解速度正常化：在甲泼尼龙中的应用
J Pharm Belg. 1971 Mar-Apr;26(2):115-34.
8
[Glidiazine in the treatment of diabetes in adult].格列氮嗪治疗成人糖尿病
Bord Med. 1970 Oct;3(10):2501-2 passim.
9
10
Pharmaceutics of cephapirin sodium (Cefadyl) a new semisynthetic cephalosporin - part III.新型半合成头孢菌素头孢匹林钠（先锋霉素Ⅷ）的药剂学 - 第三部分
Curr Ther Res Clin Exp. 1974 Nov;16(11):1214-37.
Zotero 插件